- Antitetanus Vaccination for People Older Than 65 Years.
- Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
- Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain
- Double Blind, Randomized Phase III Study to Evaluate the Immunogenicity and Safety of ‘BR-TD-1001’ Administered Intramuscularly in Healthy Children
- Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine
- Intrathecal Tetanus Immunoglobulin to Treat Tetanus
- Multicenter Study of Tetanus Patients in Fujian Province of China
- Pneumonia in Tetanus Study
- REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children
- Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
- Tdap Vaccine Safety for Plasma Donors
- Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
- The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td
- The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Clinical Trials
- Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria
- O2 Transport and Utilization in Health and Lung Disease
- Retrospective Observational Safety Effectiveness With Kuvan in hpA
- Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency
- A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System
- Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients
- The Treatment of Progressive Early Onset Spinal Deformities: A Multi-Center Outcome Study
- Tools for the Objective Clinical Assessment of Pediatric Spinal Deformity
- Vertical Expandable Prosthetic Titanium Rib (VEPTR) for Thoracic Insufficiency Syndrome
- A Study Into the Effect of Seprafilm in Open Total Thyroidectomy
- A Study of BDTX-4933 in Patients With BRAF and Select RAS/MAPK Mutation-Positive Cancers
- Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
- An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer Undergoing Radiation Therapy and/or Systemic Therapy
- Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
- Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
- Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection
- ctDNA in Patients With Thyroid Nodules
- Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
- Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
- Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System
- Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery
- Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain
- Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study
- Evaluation of a New CZT System
- Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
- Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
- Function Integrity of Neck Anatomy in Thyroid Surgery
- Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer
- Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer
- Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer
- Influence of Thyroid Hormones on the Woundhealing Process
- Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
- Lenvatinib and Pembrolizumab in DTC
- Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
- Lipid Metabolic Status in Thyroid Carcinoma
- Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
- Modified Cormack Lehane Scores Evaluated by Laryngoscopy During Awake Versus Under General Anesthesia
- Optimising Molecular Radionuclide Therapy
- Oral AMXT 1501 Dicaprate in Combination With IV DFMO
- Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
- Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
- Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
- Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
- Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
- Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine
- Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
- Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
- Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
- Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
- Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma
- Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies
- Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
- The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
- Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
- Three-dimensional Ultrasonography Thyroid Volume Measurement.
- Thyroid Cancer and Sunitinib
- Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
- Trial of LBH589 in Metastatic Thyroid Cancer
- Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
- An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
- Application of a TBE-Vaccine in Obese Persons
- Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac
- Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
- Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
- Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine
- Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
- Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination
- Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
- Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 – 67 Years
- New Study – Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
- Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases
- Primary TBE Vaccination for the Elderly
- Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
- Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
- Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
- Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
- TBE Seropersistence up to 10 Years After First Booster in Adults
- The Norwegian Tick Born Encephalitis Study
- Tick-borne Encephalitis and Borrelial Antibodies in Serum
- Tick-borne Encephalitis and Positive Borrelial Antibodies
- Tick-borne Encephalitis and Possible Borrelial Serology
- Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)
- 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
- A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
- A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
- A Study of the Effects of PEITC on Oral Cells With Mutant p53
- Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC
- Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients
- Analysis Of Sensory Recovery Of Donor Size And Quality Life In Oral Cancer Patients
- Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma
- Assessment of Mandibular Bone Invasion With MRI Using SWIFT
- Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
- Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression
- Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention
- Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
- Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
- Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
- Cell-free Tumor DNA in Head and Neck Cancer Patients
- Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
- Cigarette Smoking and Oral Microbiota
- Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
- Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
- Dental Hygienists and Dentists as Providers of Oral Mucosa Screening and Brush Biopsies
- Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography
- Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
- Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
- Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
- Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients
- Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
- Effects of EMG Visual Feedback for Spinal Accessory Nerve Dysfunction After Neck Dissection: a Randomized Clinical Trial
- Effects of Mouth-opening Training on the Maximum Interincisal Opening
- Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer – COOLS TRIAL
- Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity
- Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
- Epstein-Barr Detection in Oral Cancer
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
- Erlotinib Prevention of Oral Cancer (EPOC)
- Evaluating Oral Visual Inspection in the Control of Oral Cancer
- Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
- Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.
- Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions
- Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
- Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
- Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
- Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
- Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
- Green Tea Mouthwash on the Oral Health Status in Oral Cancer Patients
- Improved Implant for Reconstruction Purposes After Mandibular Resection
- Improving Access to Control of Diseases for Women
- IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
- Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
- Inductive Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients
- Innovative Approach to Triage Oral Precancer
- Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects.
- Least Invasive Nonlinear Light Microscopy
- LLL Phototherapy in Oral Lesions Resulting From Anti-neoplastic Treatment
- Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.
- Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings
- Mandibular Reconstruction Preplanning (ViPMR)
- MSOT Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases
- NBI in Oral Cavity Cancer
- Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
- Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
- Newer Therapeutic Targets in Head and Neck Cancers
- Oral Cancer Awareness in Egypt
- Oral Cancer Screening and Education in Hong Kong
- Oral Cancer Screening in Mumbai, India by Primary Health Care Workers
- Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
- Oral Microbioma and Oral Malignant Disease
- Oral Pathology Asynchronous Telementoring Pilot Study
- Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy – 3-years Prospective Study
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
- Patient Evaluation for Head and Neck Surgery Branch Studies
- Personalized Survivor Care Plan for Oral Cancer Patients-Effects on Physical-Psychological Functions and Return-to-Work
- PET/CT and Sentinel Node in Oral Cancer
- Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
- Physical Activities by Technology Help (PATH)
- Polarized Reflectance Spectroscopy for Oral Lesions
- Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
- Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders
- Prevention of Oral DNA Damage by Black Raspberries
- Prospective Analysis of Robot-Assisted Surgery
- Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
- Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy
- Radial Forearm Donor Site Closure
- Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
- Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
- Rehabilitation Outcomes in Head and Neck Survivors
- Rehabilitation Outcomes of Shoulder Function in Oral Cancer Survivors Cancer Survivors
- Research on Optimization and Evaluation of Oral Cancer Screening Methods
- Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue
- Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
- Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
- Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
- Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
- Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.
- Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
- Submandibular Gland Preservation in Neck Dissection
- The Link Between Periodontitis, Smoking and Oral Cancer
- the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients
- The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor
- The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer
- The Oral Microbiome in OSCC
- The Relation of Microtubule-Associated Protein 2 and Cell Migration
- The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis
- The Role of microRNA-29b in the Oral Squamous Cell Carcinoma
- The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
- The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma
- The Use of Functional Confections in Promoting Oral Health
- Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line
- Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line
- Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
- Topical Aldara (Imiquimod) for Oral Cancer
- Trial of IIb Preserving Neck Dissection
- Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients
- Understanding Non-radiotherapy-based Development of Trismus
- uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
- Use of Ultrasound for Measuring Size of Oral Tongue Cancers
- Using an APP in Post Oral Cancer Surgery to Affect Patients’ Needs and Quality of Life.
- Validation of DNA Methylation Biomarkers for Oral Cancer Detection
- Validation of DNA Methylation Biomarkers for Oral Cancer Detection
- Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study
- Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
- Web-based Education on Oral Cancer for Primary Care Physicians in Ohio
- Wild Type p53 Adenovirus for Oral Premalignancies
- Workplace Tobacco Cessation And Oral Cancer Screening Study
- A Handwriting Intervention Program for Children With Tic Disorders
- A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
- A Randomized, Placebo-controlled, Tourette Syndrome Study.
- A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette’s Syndrome
- A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
- A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome
- A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome
- A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
- A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome
- ABF Tourette’s Disorder Post Marketing Surveillance Study
- Activity in Tourette Syndrome
- Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.
- An Exploratory Study of Transcranial Magnetic Stimulation (TMS) Based on Functional Magnetic Resonance Imaging (fMRI) in the Treatment of Tic Disorder
- An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
- Anger Control Training for Youth With Tourette Syndrome
- Apathy in Tourette Syndrome and Changes in Quality of Life
- Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette’s Disorder
- Aripiprazole in the Treatment of Tourette’s Syndrome
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette’s Syndrome
- Assessment of Children With Tic Onset in the Past 6 Months
- Atomoxetine in Patients With Tourette’s Syndrome
- Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
- Behavioral Therapy for Children and Adolescents With Tourette Syndrome
- Behavioral Therapy for Tourette Syndrome
- Brain Activation in Vocal and Motor Tics
- Brain Activity Associated With Tics in Patients With Tourette Syndrome
- Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement
- Brain Stimulation for the Treatment of Tourette Syndrome
- Brain Stimulation in Movement Disorders
- Brain Tissue Collection for Neuropathological Studies
- Brain-Behavior Interactions in Tic Suppression
- CANNAbinoids in the Treatment of TICS (CANNA-TICS)
- Central Mechanisms in Speech Motor Control Studied With H215O PET
- Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
- Combined CBIT and rTMS to Improve Tourette’s Syndrome
- Comparison of Keppra and Clonidine in the Treatment of Tics
- Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome
- D-cycloserine Augmented Treatment for Youth With Tic Disorders
- Deep Brain Stimulation in Forel’s H Field in Tourette’s Syndrome
- Developing Cognitive Training for Tourette Syndrome
- Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
- Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
- Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
- Do Mirror Neurons Play a Role in Tourette Syndrome Physiopathology? A Pilot Study.
- Dopaminergic Effects on Cortical Function in Tourette’s (Levodopa Protocol)
- Ecopipam Tablets to Study Tourette’s Disorder in Children and Adolescents
- Ecopipam Treatment of Tourette Syndrome
- Ecopipam Treatment of Tourette’s Syndrome in Subjects 7-17 Years
- Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
- Effects of Lactobacillus Plantarum PS128 in Patients With Tourette’s Syndrome
- Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette’s Disorder
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette’s Disorder
- Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
- Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome
- Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette’s Disorder
- Evaluation of a Cognitive Psychophysiological Treatment for Tourette Syndrome and Tic Disorders
- Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program
- Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents
- Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device – Safety and Feasibility Study for the Treatment of Tourette Syndrome
- Exploration of Glutamatergic System With PET Radiotracer in Gilles de la Tourette Patients: Pilot Study (GlutaTour)
- Extinction Learning in Adults With Tourette Syndrome
- FAAH Inhibitor Trial for Adults With Tourette Syndrome
- Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette’s Syndrome
- Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette’s Disorder
- Group Intervention for Children With Chronic Tics Syndrome or Tourette Syndrome: CBIT vs Psycho-Educational Intervention
- Guanfacine in Children With Tic Disorders
- High Frequency Stimulation of the GPi or Thalamus in Tourette’s Syndrome
- Hypersensitivity in Tourette Syndrome
- I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers
- Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study
- Incorporating teleCBIT Into a Hospital-Based Tic Program
- Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
- Internet-based Behaviour Therapy for Tourette’s Disorder and Chronic Tic Disorder
- Internet-based Coaching for Young Adults With Neuropsychiatric Disorders
- Internet-based Cognitive Behavioral Therapy for Chronic Tic Disorder and Tourette’s Disorder: a Feasibility Trial
- Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette’s Disorder
- Investigating Circadian Rhythms in Youth With Persistent Tic Disorders
- Investigating Distress Tolerance in Adults With Tourette Syndrome
- Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders
- Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI
- Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T MRI
- Longitudinal Impact of Stressors in Adults With Tourette Syndrome
- Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome
- Median Nerve Stimulation (MNS) Pilot
- Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder
- Methylphenidate for Treating Children With ADHD and Tourette Syndrome
- Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
- MRI Study of Tic Remission in Tourette Syndrome
- Multi-site Transcranial Magnetic Stimulation Therapy of the Supplementary Motor Area in Children With Tourette Syndrome
- National Gilles De La Tourette Study Group
- Neural Correlates of Sensory Phenomena in Tourette Syndrome
- Neurofeedback for Tourette Syndrome
- Neuropsychological Functioning Among Children With Tourret’s Disorder and ADHD
- New Stereotactic Frame System for Neurosurgery
- Observational Database on Deep Brain Stimulation in Tourette Syndrome
- Omega-3 Fatty Acids in Tourette’s Disorder
- Online Mindfulness-based Tic Reduction
- Online Mindfulness-based Tic Reduction (Phase Two)
- Online Remote Behavioural Intervention for Tics (ORBIT)
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette’s Disorder
- Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome
- Open-label MNS for Tourette Syndrome
- Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
- Open-Trial of EPI-743 for Adults With Tourette Syndrome
- Optimising Anterior Pallidal Deep Brain Stimulation for Tourette’s Syndrome
- Outcomes Mandate National Integration With Cannabis as Medicine
- Pallidal Stimulation and Gilles de la Tourette Syndrome
- Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome
- Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
- Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
- Phase III Study of 5LGr to Treat Tic Disorder
- Physiological Investigations of Movement Disorders
- Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette’s Syndrome
- Pilot Study of the Modified Atkins Diet for Tourette Syndrome
- Pilot Trial of Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)
- Pimavanserin Treatment in TS
- Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
- Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome
- Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette’s Disorder
- Psychosocial Intervention for Young Children With Chronic Tics
- Randomized Study of Pergolide in Children With Tourette Syndrome
- Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
- Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome
- Repetitive Transcranial Magnetic Stimulation to Reduce Tics
- Response Inhibition in Tourette Syndrome
- Role of Frontal Cortex in the Pathophysiology of Gilles de la Tourette Syndrome (GTS)
- Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
- Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
- Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette’s Disorder
- Safety and Efficacy of Cannabis in Tourette Syndrome
- Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
- Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
- Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome
- Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette’s Disorder
- Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome
- Safety Study of Galantamine in Tic Disorders
- Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
- Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
- Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette’s Disorder
- SCI-110 in the Treatment of Tourette Syndrome
- Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
- Selective Microbiota Transplantation for Tourette’s Syndrome
- Sensory Processing in Tourette Syndrome
- Sensory Symptoms in Tourette Syndrome
- Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder
- Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
- Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette’s Disorder
- Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette’s Syndrome
- Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
- Study of Clonidine on Sleep Architecture in Children With Tourette’s Syndrome (TS) and Comorbid ADHD
- Study of GABA-A Receptors in the Generation of Tics in Patients With Tourette’s Syndrome
- Study of the Neurobiology of Tourette Syndrome and Related Disorders
- Study of Tics in Patients With Tourette’s Syndrome and Chronic Motor Tic Disorder
- Subthalamic Stimulation in Tourette’s Syndrome
- tDCS in Tourette (TIC-TDCS)
- Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
- Thalamic Deep Brain Stimulation for Tourette Syndrome
- Thalamic Deep Brain Stimulation for Tourette Syndrome
- The Effect and Safety of Plum-blossom Needle for Tourette Syndrome
- The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome
- The Pathophysiology of Tourette Syndrome: a Multimodal Study
- The Role of Probiotics PS128 in Movement Disorders
- The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome
- Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome
- TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)
- Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder
- Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression
- Tourette Discrimination (TD) Stigma Scale
- Tourette Syndrome and Seasonality (Stagionalità Tourette)
- Tourette Syndrome Deep Brain Stimulation
- Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette’s Syndrome
- Transcranial Magnetic Stimulation for Children With Tourette’s Syndrome
- Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics
- Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
- Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette’s Disorder
- VoIP Delivered Behavior Therapy for Tourette Syndrome
- Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
- Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
- Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
- Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
- Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
- Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
- Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
- Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren’s Syndrome, and Graft Vs Host Disease
- G-CSF in the Treatment of Toxic Epidermal Necrolysis
- HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction
- Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
- Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
- LYell SYndrome MEsenchymal Stromal Cells Treatment
- Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
- NATIENS: Optimal Management and Mechanisms of SJS/TEN
- Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
- Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
- Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation
- Severe Bullous Drug Eruption and Filgrastim
- Severe Cutaneous Adverse Reactions in Thailand
- Stevens-Johnson Syndrome Antimicrobial
- Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
- Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
- Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
- Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
- Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
- Airway Stents for Excessive Dynamic Airway Collapse
- Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
- Effect of CPAP on 6-Minute Walk Test Outcomes in Patients With ECAC
- Efficacy and Safety Evaluation of HCPA-1 Silicone Stent in the Treatment of Central Airway Obstructions
- Matrix Biology of Tracheobronchomalacia and Tracheal Stenosis
- PEEP Mask for TBM-Induced Cough
- Pressure Dependent Tracheal Obstruction in Copd Patients
- Symptomatic Treatment of Excessive Dynamic Airway Collapse Using Daytime Portable Continuous Positive Airway Pressure
- The Effect of Bethanechol on Tracheobronchomalacia
- Tracheal Mechanics During Bronchoscopy
- Tracheobronchomalacia: Treatment Outcomes
- A Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months
- Adipose Derived SVF for Aero-digestive Fistulae
- Cerebral Blood Flow in Neonates During Thoracoscopic Surgeries
- Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device
- Inverse Ratio Ventilation in Neonatal Open Repair of Tracheoesophageal Fistula.
- Phenotypic and Genetic Assessment of Tracheal and Esophageal Birth Defects in Patients
- Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery
- Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair
- Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair
- A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
- A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery
- App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders
- Azithromycin in Control of Trachoma II
- Azithromycin Reduction to Reach Elimination of Trachoma
- Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
- Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania
- Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma
- Enhancing the A in SAFE for Trachoma
- Fluorometholone as Ancillary Therapy for TT Surgery
- Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
- Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger
- Kebele Elimination of Trachoma for Ocular Health
- Modified Instrumentation for Surgery to Correct Trichiasis
- Nepal Elimination of Trachoma Study
- Partnership for Rapid Elimination of Trachoma
- Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
- Safety and Immunogenicity of a Chlamydia Vaccine CTH522
- Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
- Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis
- Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
- Smartphone App for Taking Images of Conjunctivae
- Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania
- Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma
- Trachoma Amelioration in Northern Amhara (TANA)
- Trachoma Elimination Follow-up
- Trachoma Elimination Study by Focused Antibiotic (TESFA)
- Tripartite International Research for the Elimination of Trachoma
- Water Uptake for Health in Amhara Pilot
- 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
- 89Zr-girentuximab PET in Urothelial Cancer Patients
- A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma
- A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
- A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors ( PIVOT-02 )
- A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
- A Multicenter Cancer Biospecimen Collection Study
- A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
- A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
- A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer
- A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
- A PHASE 1/2 STUDY OF BA3071
- A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
- A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
- A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
- A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
- A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
- A PHASE II MULTICENTER STUDY OF CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS DURVALUMAB (MEDI 4736) IN PATIENTS WITH LYMPH NODE POSITIVE UROTHELIAL CARCINOMA OF THE BLADDER
- A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
- A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer
- A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
- A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up
- A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors
- A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
- A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy
- A Single-centre, Open-label, Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP Study)
- A Study Combining the M3814 Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer Patients
- A Study Evaluating MM-310 in Patients With Solid Tumors
- A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-based Treatment Combinations in Patients With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
- A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
- A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 (Pembrolizumab) in Patients With Select Advanced or Metastatic Solid Tumors
- A Study of a Personalized Neoantigen Cancer Vaccine
- A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
- A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
- A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies
- A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
- A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
- A Study of CDX-585 in Patients With Advanced Malignancies
- A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
- A Study of ICP-192 in Patients With Advanced Solid Tumors
- A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy
- A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
- A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
- A Study of Personalized Neoantigen Cancer Vaccines
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
- A Study of RC48-ADC Combined With Triplizumab For First-line Treatment of Urothelial Carcinoma
- A Study of RC48-ADC in Patients With HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma
- A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer
- A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer
- A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- A Study of the Safety and Tolerance of CAN04 in Combination With Pembrolizumab in Subjects With Solid Tumors
- A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
- A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
- A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- A Study of ZN-c3 in Participants With Solid Tumors
- A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma
- A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations
- A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
- A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)
- A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283 (Cetrelimab), an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Locally Advanced Urothelial Cancer With Selected FGFR Gene Alterations
- A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
- A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
- A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
- A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)
- A Study to Learn About First-line Avelumab Maintenance in Japanese Patients With Locally Advanced or Metastatic Urothelial Carcinoma
- A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
- A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)
- A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
- Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer
- ADAPT-BLADDER: Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder
- Alisertib in Chemotherapy-pretreated Urothelial Cancer
- An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
- An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
- An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma
- Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
- Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma
- Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
- APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
- Application of UCAD for Diagnosing Urothelial Carcinoma.
- Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
- Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
- ARON-2 Study-Multicentric International Retrospective Study
- Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma
- Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
- Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer
- Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
- B-Receptor Signaling in Cardiomyopathy
- BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
- Bio Clinical Collection of Urothelial Carcinoma
- Biological Effect of Vitamin D in Patients With Urothelial Carcinoma
- Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
- Bladder Cancer Screening Trial
- Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
- Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
- Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
- Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
- Cabozantinib for Advanced Urothelial Cancer
- Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.
- Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
- CHEckpoint Inhibition in Combination With an Immunoboost of External Body Radiotherapy in Solid Tumors
- Checkpoint Inhibition With or Without Domatinostat in Urothelial Cancer
- Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
- CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
- Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
- Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
- Confocal Laser Endomicroscopy in the Lower Urinary Tract
- Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy
- CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
- Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
- Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
- Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
- Derazantinib and Atezolizumab in Patients With Urothelial Cancer
- Detecting Transitional Cell Carcinoma From Haematuria
- Development of Diagnostics and Treatment of Urological Cancers
- Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
- Diagnostic Values of Urothelial Carcinomas: Single-bolus Versus Split-bolus Computed Tomography Urography
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
- DNA Methylation and Arsenic-associated Urothelial Carcinoma
- DNA Methylation and Urothelial Carcinoma
- Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications
- Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial
- Efficacy and Safety of UGN-101 in Recurrent Patients
- Efficacy and Utility of Cxbladder Tests in Hematuria Patients
- Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
- EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells
- En Bloc TURBT With Collins Loop vs Conventional TURBT
- Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
- Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
- Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
- Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction
- Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
- Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas
- Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study
- Expressing Personalized Tumor Antigens Study
- Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
- Fear of Cancer Recurrence in Genitourinary Cancer
- Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
- Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC)
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
- First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
- First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma
- FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
- Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
- GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy
- GEN1046 Safety Trial in Patients With Malignant Solid Tumors
- Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
- Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
- Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
- Improve Checkpoint-blockade Response in Advanced Urothelial Cancer
- Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Intravesical Adoptive Cell Therapy w/ TIL for BCG Unresponsive High Grade NMIBC
- Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT
- Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
- Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:
- IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
- ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin
- JAVLOR® Online Non-Interventional Trial
- KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer
- KYN-175 in Patients With Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- LITT and Pembrolizumab in Recurrent Brain Metastasis
- Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
- Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer
- MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
- Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy
- Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer
- Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
- Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
- MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer
- MV-NIS or Investigator’s Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer
- Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
- Named Patient Program for Mitomycin for Pyelocalyceal Solution
- Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
- Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
- Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer
- Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma
- Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy
- Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
- Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
- Neoadjuvant Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma
- Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
- Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma
- Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma
- Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
- Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
- Patient-reported Outcomes in Bladder Cancer
- Pembrolizumab in MIBC
- Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
- Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma
- Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy
- PF-03446962 in Relapsed or Refractory Urothelial Cancer
- Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
- Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors
- Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma
- Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
- Phase I BLASST-3 Trial
- Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
- Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
- Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
- Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies
- Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma
- Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer
- Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
- Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
- Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
- Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma
- Predictive Factorsfor Final Pathologic Ureteral Sections
- Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder
- Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
- Prospective Multicentric Evaluation of a Bladder Preservation Strategy
- Prospective Trial for Examining Hematuria Using Computed Tomography
- PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas
- Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
- QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer
- Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
- Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
- Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
- Registry Platform Urologic Cancer
- Relationship of Ochratoxin A to Upper Urologic Cancers
- Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients
- Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
- RTX-224 Monotherapy in Patients With Solid Tumors
- Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
- SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma
- Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
- Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
- Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors
- Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
- Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
- Single Agent Abraxane as Second Line Therapy in Bladder Cancer
- SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
- Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
- Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
- Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
- Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
- Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)
- Study of INBRX-105 in Patients With Solid Tumors, Hodgkin or Non-Hodgkin Lymphoma
- Study of INBRX-106 in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes
- Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma
- Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection
- Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint Inhibitor
- Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer
- Study of Sitravatinib and Nivolumab in Urothelial Carcinoma
- Study of the CD40 Agonistic Monoclonal Antibody APX005M
- Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
- Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
- Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors
- Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
- Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
- Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker
- Surpass: ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Tumors
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
- Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial
- Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
- Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
- Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer
- The Cxbladder Hematuria Clinical Utility Study
- The Cxbladder Monitoring Study
- The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence
- The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
- The Effects of Moderate Exercise on Distress, Quality of Life, and Biomarkers of Angiogenesis and Chronic Stress in Ovarian Cancer Survivors
- The Efficacy and Safety of UGN-102 as a Primary Chemoablative Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence
- The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer
- TPST-1120 as Monotherapy and in Combination With (Nivolumab, Docetaxel or Cetuximab) in Subjects With Advanced Cancers
- Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
- TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
- Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
- Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma
- Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
- Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
- Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy
- Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma
- Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
- UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch
- UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.
- Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic
- Urothelial Tumor Risk Genes Detection With Genetron Uro V1
- Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
- Vactosertib With Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition
- Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population
- Vasculogenic Mimicry in Urothelial Carcinoma
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
- Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
- Water Versus Saline as Irrigation Fluid for Ureteroscopy
- Weekly TP-HDFL in the Treatment of Advanced TCC
- Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program